Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort
Renaud Felten(Centre National de la Recherche Scientifique), Jacques‐Eric Gottenberg(Hôpitaux Universitaires de Strasbourg), Thibaut Fabacher(Université de Strasbourg), N. Sedmak(Hôpitaux Universitaires de Strasbourg), Olivier Vittecoq(Centre Hospitalier Universitaire de Rouen), Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Françis Berenbaum(Inserm), Bernard Combe(Université de Montpellier), Nicolás Meyer, Adeline Ruyssen‐Witrand(Centre Hospitalier Universitaire de Toulouse)
Cited by 3
Related Papers
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
|Annals of the Rheumatic Diseases|2006|798
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432